pmc logo image
Logo of thoraxThoraxInstructions for authorsInstructions for authors
Journal List > Thorax > v.58(9); Sep 2003

Formats:
Thorax. 2003 September; 58(9): 809–813.
doi: 10.1136/thorax.58.9.809.
PMCID: PMC1746789
Copyright notice
Lung cancer • 8: Management of malignant mesothelioma
C Parker and E Neville
Respiratory Centre, St Mary's Hospital, Portsmouth PO3 6AD, Hants, UK.
Small right arrow pointing to: This article has been cited by other articles in PMC.
Full Text
The Full Text of this article is available as a PDF (113K).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Peto J, Hodgson JT, Matthews FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet. 1995 Mar 4;345(8949):535–539. [PubMed]
  • Boutin C, Schlesser M, Frenay C, Astoul P. Malignant pleural mesothelioma. Eur Respir J. 1998 Oct;12(4):972–981. [PubMed]
  • Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer. 1999 Feb;79(3-4):666–672. [PubMed]
  • Hubbard R. The aetiology of mesothelioma: are risk factors other than asbestos exposure important? Thorax. 1997 Jun;52(6):496–497. [PubMed]
  • Yates DH, Corrin B, Stidolph PN, Browne K. Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax. 1997 Jun;52(6):507–512. [PubMed]
  • WAGNER JC, SLEGGS CA, MARCHAND P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960 Oct;17:260–271. [PubMed]
  • Gibbs AR. Role of asbestos and other fibres in the development of diffuse malignant mesothelioma. Thorax. 1990 Sep;45(9):649–654. [PubMed]
  • Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, Smith A. Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst. 1981 Nov;67(5):965–975. [PubMed]
  • Davis JM, Addison J, Bolton RE, Donaldson K, Jones AD, Smith T. The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol. 1986 Jun;67(3):415–430. [PubMed]
  • Elmes PC, Simpson JC. The clinical aspects of mesothelioma. Q J Med. 1976 Jul;45(179):427–449. [PubMed]
  • Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest. 1983 Oct;77(4):321–343. [PubMed]
  • Law MR, Hodson ME, Heard BE. Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax. 1982 Nov;37(11):810–815. [PubMed]
  • Gardner MJ, Jones RD, Pippard EC, Saitoh N. Mesothelioma of the peritoneum during 1967-82 in England and Wales. Br J Cancer. 1985 Jan;51(1):121–126. [PubMed]
  • Browne K, Smither WJ. Asbestos-related mesothelioma: factors discriminating between pleural and peritoneal sites. Br J Ind Med. 1983 May;40(2):145–152. [PubMed]
  • Moertel CG. Peritoneal mesothelioma. Gastroenterology. 1972 Aug;63(2):346–350. [PubMed]
  • Antman KH, Pomfret EA, Aisner J, MacIntyre J, Osteen RT, Greenberger JS. Peritoneal mesothelioma: natural history and response to chemotherapy. J Clin Oncol. 1983 Jun;1(6):386–391. [PubMed]
  • Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax. 1976 Feb;31(1):15–24. [PubMed]
  • Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer. 1996 Feb;14(1):1–12. [PubMed]
  • Sugarbaker DJ, Strauss GM, Lynch TJ, Richards W, Mentzer SJ, Lee TH, Corson JM, Antman KH. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol. 1993 Jun;11(6):1172–1178. [PubMed]
  • Rusch VW, Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 1996 Apr;111(4):815–826. [PubMed]
  • Leung AN, Müller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol. 1990 Mar;154(3):487–492. [PubMed]
  • Heelan RT. CT and MR imaging in the evaluation of pleural masses. Chest Surg Clin N Am. 1994 Aug;4(3):431–450. [PubMed]
  • Layer G, van Kaick G. Mesotheliom der Pleura--Diagnostik durch bildgebende Verfahren. Langenbecks Arch Chir Suppl Kongressbd. 1992:173–179. [PubMed]
  • Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, DeCamp MM, Jr, Swanson SJ, Bueno R, Lukanich JM, Baldini EH, Mentzer SJ. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999 Jan;117(1):54–65. [PubMed]
  • Patz EF, Jr, Shaffer K, Piwnica-Worms DR, Jochelson M, Sarin M, Sugarbaker DJ, Pugatch RD. Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. AJR Am J Roentgenol. 1992 Nov;159(5):961–966. [PubMed]
  • Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES. The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest. 1997 Jan;111(1):106–109. [PubMed]
  • Whitaker D, Shilkin KB. Diagnosis of pleural malignant mesothelioma in life--a practical approach. J Pathol. 1984 Jul;143(3):147–175. [PubMed]
  • Adams RF, Gray W, Davies RJ, Gleeson FV. Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma. Chest. 2001 Dec;120(6):1798–1802. [PubMed]
  • Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer. 1993 Jul 15;72(2):389–393. [PubMed]
  • Hansen M, Faurschou P, Clementsen P. Medical thoracoscopy, results and complications in 146 patients: a retrospective study. Respir Med. 1998 Feb;92(2):228–232. [PubMed]
  • Van Gelder T, Damhuis RA, Hoogsteden HC. Prognostic factors and survival in malignant pleural mesothelioma. Eur Respir J. 1994 Jun;7(6):1035–1038. [PubMed]
  • Ceresoli GL, Locati LD, Ferreri AJ, Cozzarini C, Passoni P, Melloni G, Zannini P, Bolognesi A, Villa E. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer. 2001 Nov;34(2):279–287. [PubMed]
  • Ribak J, Selikoff IJ. Survival of asbestos insulation workers with mesothelioma. Br J Ind Med. 1992 Oct;49(10):732–735. [PubMed]
  • Sugarbaker DJ, Garcia JP, Richards WG, Harpole DH, Jr, Healy-Baldini E, DeCamp MM, Jr, Mentzer SJ, Liptay MJ, Strauss GM, Swanson SJ. Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg. 1996 Sep;224(3):288–296. [PubMed]
  • Sterman DH, Kaiser LR, Albelda SM. Advances in the treatment of malignant pleural mesothelioma. Chest. 1999 Aug;116(2):504–520. [PubMed]
  • Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg. 1991 Jul;102(1):1–9. [PubMed]
  • Ong ST, Vogelzang NJ. Chemotherapy in malignant pleural mesothelioma. A review. J Clin Oncol. 1996 Mar;14(3):1007–1017. [PubMed]
  • Ryan CW, Herndon J, Vogelzang NJ. A review of chemotherapy trials for malignant mesothelioma. Chest. 1998 Jan;113(1 Suppl):66S–73S. [PubMed]
  • Astoul P. Pleural mesothelioma. Curr Opin Pulm Med. 1999 Jul;5(4):259–268. [PubMed]
  • Baas P, Schouwink H, Zoetmulder FA. Malignant pleural mesothelioma. Ann Oncol. 1998 Feb;9(2):139–149. [PubMed]
  • Markman M, Cleary S, Pfeifle C, Howell SB. Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma. Cancer. 1986 Jul 1;58(1):18–21. [PubMed]
  • Häkkinen AM, Laasonen A, Linnainmaa K, Mattson K, Pyrhönen S. Radiosensitivity of mesothelioma cell lines. Acta Oncol. 1996;35(4):451–456. [PubMed]
  • Gordon W, Jr, Antman KH, Greenberger JS, Weichselbaum RR, Chaffey JT. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys. 1982 Jan;8(1):19–25. [PubMed]
  • Brady LW. Mesothelioma--the role for radiation therapy. Semin Oncol. 1981 Sep;8(3):329–334. [PubMed]
  • Moskal TL, Urschel JD, Anderson TM, Antkowiak JG, Takita H. Malignant pleural mesothelioma: a problematic review. Surg Oncol. 1998 Jul–Aug;7(1-2):5–12. [PubMed]
  • Alberts AS, Falkson G, Goedhals L, Vorobiof DA, Van der Merwe CA. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol. 1988 Mar;6(3):527–535. [PubMed]
  • Calavrezos A, Koschel G, Hüsselmann H, Taylessani A, Heilmann HP, Fabel H, Schmoll HJ, Dietrich H, Hain E. Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981-1985. Klin Wochenschr. 1988 Jul 15;66(14):607–613. [PubMed]
  • Baldini EH, Recht A, Strauss GM, DeCamp MM, Jr, Swanson SJ, Liptay MJ, Mentzer SJ, Sugarbaker DJ. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg. 1997 Feb;63(2):334–338. [PubMed]
  • Solomons K. Malignant mesothelioma--clinical and epidemiological features. A report of 80 cases. S Afr Med J. 1984 Sep 15;66(11):407–412. [PubMed]
  • Lee YC, Light RW, Musk AW. Management of malignant pleural mesothelioma: a critical review. Curr Opin Pulm Med. 2000 Jul;6(4):267–274. [PubMed]
  • Sahn SA. Management of malignant pleural effusions. Monaldi Arch Chest Dis. 2001 Oct;56(5):394–399. [PubMed]
  • Sahin U, Unlü M, Akkaya A, Ornek Z. The value of small-bore catheter thoracostomy in the treatment of malignant pleural effusions. Respiration. 2001;68(5):501–505. [PubMed]
  • Sahn SA. Pleural effusion in lung cancer. Clin Chest Med. 1993 Mar;14(1):189–200. [PubMed]
  • Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest. 1994 Oct;106(4):1215–1222. [PubMed]
  • Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994 Jan 1;120(1):56–64. [PubMed]
  • Hartman DL, Gaither JM, Kesler KA, Mylet DM, Brown JW, Mathur PN. Comparison of insufflated talc under thoracoscopic guidance with standard tetracycline and bleomycin pleurodesis for control of malignant pleural effusions. J Thorac Cardiovasc Surg. 1993 Apr;105(4):743–748. [PubMed]
  • Gravelyn TR, Michelson MK, Gross BH, Sitrin RG. Tetracycline pleurodesis for malignant pleural effusions. A 10-year retrospective study. Cancer. 1987 Jun 1;59(11):1973–1977. [PubMed]
  • Kessinger A, Wigton RS. Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study. J Surg Oncol. 1987 Oct;36(2):81–83. [PubMed]
  • Putnam JB, Jr, Light RW, Rodriguez RM, Ponn R, Olak J, Pollak JS, Lee RB, Payne DK, Graeber G, Kovitz KL. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer. 1999 Nov 15;86(10):1992–1999. [PubMed]
  • Bloom AI, Wilson MW, Kerlan RK, Jr, Gordon RL, LaBerge JM. Talc pleurodesis through small-bore percutaneous tubes. Cardiovasc Intervent Radiol. 1999 Sep–Oct;22(5):433–436. [PubMed]
  • Rinaldo JE, Owens GR, Rogers RM. Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg. 1983 Apr;85(4):523–526. [PubMed]
  • Marom EM, Patz EF, Jr, Erasmus JJ, McAdams HP, Goodman PC, Herndon JE. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis. Radiology. 1999 Jan;210(1):277–281. [PubMed]
  • Seaton KG, Patz EF, Jr, Goodman PC. Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy. AJR Am J Roentgenol. 1995 Mar;164(3):589–591. [PubMed]
  • Parker LA, Charnock GC, Delany DJ. Small bore catheter drainage and sclerotherapy for malignant pleural effusions. Cancer. 1989 Sep 15;64(6):1218–1221. [PubMed]
  • Little AG, Kadowaki MH, Ferguson MK, Staszek VM, Skinner DB. Pleuro-peritoneal shunting. Alternative therapy for pleural effusions. Ann Surg. 1988 Oct;208(4):443–450. [PubMed]
  • Pien GW, Gant MJ, Washam CL, Sterman DH. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest. 2001 Jun;119(6):1641–1646. [PubMed]
  • Genc O, Petrou M, Ladas G, Goldstraw P. The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions. Eur J Cardiothorac Surg. 2000 Aug;18(2):143–146. [PubMed]
  • Waller DA, Morritt GN, Forty J. Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest. 1995 May;107(5):1454–1456. [PubMed]
  • Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2000;(3):CD001133–CD001133. [PubMed]
  • Ross EL. The evolving role of antiepileptic drugs in treating neuropathic pain. Neurology. 2000;55(5 Suppl 1):S41–S58. [PubMed]
  • Middleton GW, Smith IE, O'Brien ME, Norton A, Hickish T, Priest K, Spencer L, Ashley S. Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma. Ann Oncol. 1998 Mar;9(3):269–273. [PubMed]
  • Girling David J, Muers Martin F, Qian Wendi, Lobban Dawn. Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council. Semin Oncol. 2002 Feb;29(1):97–101. [PubMed]
  • Jackson MB, Pounder D, Price C, Matthews AW, Neville E. Percutaneous cervical cordotomy for the control of pain in patients with pleural mesothelioma. Thorax. 1999 Mar;54(3):238–241. [PubMed]
  • Watson PN, Evans RJ. Intractable pain with lung cancer. Pain. 1987 May;29(2):163–173. [PubMed]
  • Ischia S, Ischia A, Luzzani A, Toscano D, Steele A. Results up to death in the treatment of persistent cervico-thoracic (Pancoast) and thoracic malignant pain by unilateral percutaneous cervical cordotomy. Pain. 1985 Apr;21(4):339–355. [PubMed]
  • Rosomoff HL, Brown CJ, Sheptak P. Percutaneous radiofrequency cervical cordotomy: technique. J Neurosurg. 1965 Dec;23(6):639–644. [PubMed]
  • Lahuerta J, Bowsher D, Lipton S, Buxton PH. Percutaneous cervical cordotomy: a review of 181 operations on 146 patients with a study on the location of "pain fibers" in the C-2 spinal cord segment of 29 cases. J Neurosurg. 1994 Jun;80(6):975–985. [PubMed]
  • Davis SR, Tan L, Ball DL. Radiotherapy in the treatment of malignant mesothelioma of the pleura, with special reference to its use in palliation. Australas Radiol. 1994 Aug;38(3):212–214. [PubMed]
  • Gordon W, Jr, Antman KH, Greenberger JS, Weichselbaum RR, Chaffey JT. Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys. 1982 Jan;8(1):19–25. [PubMed]
  • Bissett D, Macbeth FR, Cram I. The role of palliative radiotherapy in malignant mesothelioma. Clin Oncol (R Coll Radiol). 1991 Nov;3(6):315–317. [PubMed]
  • Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy. Chest. 1995 Sep;108(3):754–758. [PubMed]
  • Low EM, Khoury GG, Matthews AW, Neville E. Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy. Clin Oncol (R Coll Radiol). 1995;7(5):317–318. [PubMed]
  • Boutin C, Irisson M, Rathelot P, Petite JM. L'extension pariétale des mésothéliomes pleuraux malins diffus après biopsies. Prévention par radiothérapie locale. Presse Med. 12(29):1823. [PubMed]
  • Bruera E. Pharmacological treatment of cachexia: any progress? Support Care Cancer. 1998 Mar;6(2):109–113. [PubMed]
Articles from Thorax are provided here courtesy of
BMJ Group

PubMed articles by these authors

Links